Coaching Programme for Preceptorship of Undergraduate Nurses' Students

January 2, 2023 updated by: Clinica Universidad de Navarra, Universidad de Navarra

Coaching Programme to Improve Nurses' Perceptions of Preceptorship of Undergraduate Students: An Exploratory Trial

Background: During the curricular practices of the Bachelor's Degree in Nursing, students are prepared to carry out an adequate transition process to the professional role. The success of this preparation depends, to a large extent, on preceptorship. In this sense, it is important that practice tutors are motivated and feel competent to teach in the clinical setting. Despite this, no studies have been found that implement and evaluate an intervention to improve nurses' perceptions of preceptorship of undergraduate nursing students.

Purpose: To evaluate the preliminary efficacy of a coaching programme to improve nurses' perceptions of preceptorship of undergraduate nursing students. Specifically, the aim is to determine the impact of the programme on nurses' perceived involvement, motivation, satisfaction, barriers and commitment to clinical mentoring.

Method: An exploratory pre-post quasi-experimental pilot study. Fifteen nurses, the total population of nurses working in the medical-surgical ward, with at least 1 year of experience in the preceptorship of students, will be recruited in June 2022. All the nurses will receive an intervention based on coaching. The strategies of this program consisted of five 6-hour sessions using case studies and role-playing simulations to work on their motivation to develop their teaching role in the preceptorship of undergraduate nursing students and debriefing and a 4-hour booster session seven months later. The IMSOC (involvement, motivation, satisfaction, obstacles and commitment) instrument was used to assess outcomes. The primary outcome was the difference in the median of nurses' involvement, motivation, satisfaction, barriers and commitment in preceptorship students pre and post-intervention (between T0-T1 and T0-T2). Changes within nurses were analyzed using the Wilcoxon test for related samples.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Data collection:

Data collection was divided into three times: T0, T1 and T2. T0 corresponds to preintervention data and T1 and T2 to post-intervention data (T1 after the training and T2 after the whole intervention implementation).

IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) questionnaire. This questionnaire measures the involvement, motivation, satisfaction, obstacles and commitment of nurses in tutoring students. It is a validated instrument that shows adequate psychometric properties (overall Intraclass Correlation Coefficient (ICC) of 0.852 and internal consistency - Cronbach's α of 0.837). It consists of 33 items measured on a 5-point Likert scale (1=strongly disagree - 5=strongly agree).

Ethical considerations:

This study conformed to the principles set out in the Declaration of Helsinki and was approved by the centre's board and by the Research Ethics Committee (code 2022.044). Data custody complied with Organic Law 3/2018 on data protection (LOPDE). Informed consents were given to all participants. They were informed verbally and in writing about their free participation, the confidentiality of the data and its use for scientific purposes.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Pamplona, Spain
        • University of Navarra
      • Pamplona, Spain, 31008
        • Navarre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Clinical nurses working in the medical-surgical ward during the time of the intervention evaluation were the target population from which the sample was taken.

Description

  • Inclusion Criteria:

    • Nurses working in the medical-surgical ward.
    • Nurses with at least one year's experience in the preceptorship of students.
    • Nurses who have voluntarily agreed to participate in the study.

  • Exclusion Criteria:

    • Nurses who are not working during the time of the study (sick leave or maternity leave).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) Questionnaire
Time Frame: T0 (2022 September-October)

Nurses' involvement, motivation, satisfaction, barriers and commitment in preceptorship students

Measurement tool: IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) Questionnaire.

  • Involvement: 8 items measured on a 5-point Likert scale [8=unsuitable - 40=excellent].
  • Motivation: 8 items measured on a 5-point Likert scale [8=unsuitable - 40=excellent].
  • Satisfaction: 6 items measured on a 5-point Likert scale [6=unsuitable - 30=excellent].
  • Obstacles: 6 items measured on a 5-point Likert scale [6=unsuitable - 30=excellent].
  • Commitment: 5 items measured on a 5-point Likert scale [5=unsuitable - 25=excellent].
T0 (2022 September-October)
IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) Questionnaire
Time Frame: T1 (2022 November)

Nurses' involvement, motivation, satisfaction, barriers and commitment in preceptorship students

Measurement tool: IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) Questionnaire.

  • Involvement: 8 items measured on a 5-point Likert scale [8=unsuitable - 40=excellent].
  • Motivation: 8 items measured on a 5-point Likert scale [8=unsuitable - 40=excellent].
  • Satisfaction: 6 items measured on a 5-point Likert scale [6=unsuitable - 30=excellent].
  • Obstacles: 6 items measured on a 5-point Likert scale [6=unsuitable - 30=excellent].
  • Commitment: 5 items measured on a 5-point Likert scale [5=unsuitable - 25=excellent].
T1 (2022 November)
IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) Questionnaire
Time Frame: T2 (2023 May)

Nurses' involvement, motivation, satisfaction, barriers and commitment in preceptorship students

Measurement tool: IMSOC (Involvement, Motivation, Satisfaction, Obstacles and Commitment) Questionnaire.

  • Involvement: 8 items measured on a 5-point Likert scale [8=unsuitable - 40=excellent].
  • Motivation: 8 items measured on a 5-point Likert scale [8=unsuitable - 40=excellent].
  • Satisfaction: 6 items measured on a 5-point Likert scale [6=unsuitable - 30=excellent].
  • Obstacles: 6 items measured on a 5-point Likert scale [6=unsuitable - 30=excellent].
  • Commitment: 5 items measured on a 5-point Likert scale [5=unsuitable - 25=excellent].
T2 (2023 May)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Clinica Universidad de Navarra, Universidad de Navarra

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Mónica Vázquez-Calatayud, PhD, University of Navarra

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 15, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 1, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 12, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 18, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 19, 2022

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 4, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 2, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • CPMS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings